Avid Radiopharmaceuticals
Stephen Boyle has extensive experience in finance and accounting, currently serving as Controller at Avid Radiopharmaceuticals since June 2009, where previous roles included Director of Finance and Accounting, Associate Director of Accounting, Accounting Manager, and Senior Accountant. Prior to Avid Radiopharmaceuticals, Stephen Boyle worked as a Senior Accountant at Robinson Luggage from June 2007 to June 2009, and held the position of Staff Accountant at AC Moore from 2003 to 2007. Stephen Boyle earned a Bachelor's degree in Finance from Saint Joseph's University, attending from 1999 to 2003.
Avid Radiopharmaceuticals
1 followers
At Avid, a wholly owned subsidiary of Eli Lilly and Company, our mission is to develop new molecular imaging agents capable of changing the medical management of significant chronic human diseases. We have assembled an outstanding management team with extensive imaging and CNS development experience to help make pre-symptomatic disease detection a reality. Avid's pipeline of imaging compounds has the potential to dramatically alter the clinical course of challenging conditions such as Alzheimer's disease, Dementia with Lewy Bodies, Parkinson's disease and Diabetes Mellitus. This may be possible because our molecular imaging compounds may be able to detect the first stages of pathological change; allowing early treatment and management of people at risk - perhaps before before symptoms of disease can develop.